Influences of Different Polychlorinated Biphenyls on Cytocidal, Mitoinhibitory, and Nodule-Selecting Activities of N-2-Fluorenylacetamide in Rat Liver23
Authors:
- M. Anthony HayesMHM. Anthony Hayes
- Esther RobertsEREsther Roberts
- Stephen H. SafeSSStephen H. Safe
- Emmanuel FarberEFEmmanuel Farber
- Ross G. CameronRCRoss G. Cameron
- 1 April 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 76 (4) , 683-691
Abstract
The influences of different polychlorinated biphenyl (PCB) isomers and congeners on distinct hepatotoxic responses to the hepatocarcinogen N-2-fluorenylacetamide [(2-FAA) CAS: 53-96-3] were examined in F344 rats. Cytocidal toxicity of 2-FAA (25–400 µM), determined by lactate dehydrogenase release during 20 hours in primary monolayer cultures of isolated rat hepatocytes, was reduced by in vivo pretreatment with either phenobarbitone [(PB) CAS: 50-06-6] or 2,2′,4,4′,5,5′-hexachlorobiphenyl (HCBP), a PB-type PCB inducer. However, cytocidal toxicity of 2-FAA was substantially potentiated by either 3-methylcholanthrene [(MCA) CAS: 56-49-5] or 3,3′,4,4′-tetrachlorobiphenyl [(TCBP) CAS: 32598-13-3], an MCA-type PCB. In the same cell culture assays, all four pretreatments similarly reduced cytocidal toxicity of N-hydroxy-N-2-fluorenylacetamide (0.32–32 µM; CAS: 53-95-2). By comparison, pretreatments with either the PB-type or MCA-type PCB's (50–200 µmol/kg) diminished mitoinhibitory toxicity of 2-FAA in vivo, as measured by hepatic regenerative growth and hepatocyte labeling indices 7 days after partial hepatectomy (PH) in rats given 3 consecutive daily doses of 2-FAA (20/mg/kg/day) before PH. This regimen of 2-FAA and PH promoted rapid selective growth of γ-glutamyltranspeptidase-positive (γ-GT+) nodules at 2 and 4 weeks after PH in rats previously given an initiating hepatocarcinogen, diethylnitrosamine [(DENA) CAS: 55-18-5]. However, various PCB's, including 2,2′,4,4′,5,5′-HCBP, 3,3′,4,4′-TCBP, 2,2′,4,4′-TCBP, 2,2′,5,5′-TCBP, and the commercial mixture Aroclor 1254, each given as a single dose of 50 µmol/kg by gavage 10 days after DENA and 7 days before 2-FAA, all reduced the size of 2-FAA-selected γ-GT+ nodules during the 4-week period after PH. These results indicate that, in spite of predictable inducerspecific opposite influences of different types of PCB's on cytocidal toxicity of 2-FAA, all PCB's similarly reduce nodule selection by 2-FAA in initiated livers. Reduced growth of 2-FAA-selected nodules correlated with the consistent ability of all PCB's to enhance regeneration of liver mass after 2-FAA and PH.Keywords
This publication has 33 references indexed in Scilit:
- A comparison of the changes induced in rat liver by feeding low levels of aflatoxin B1 or an azo dyeBritish Journal of Cancer, 1978
- SOME CURRENT PERSPECTIVES ON CHEMICAL CARCINOGENESIS IN HUMANS AND EXPERIMENTAL-ANIMALS - PRESIDENTIAL-ADDRESS1978
- GAMMA-GLUTAMYLTRANSFERASE IN PUTATIVE PREMALIGNANT LIVER-CELL POPULATIONS DURING HEPATOCARCINOGENESIS1978
- Chlorinated Biphenyl Induction of Aryl Hydrocarbon Hydroxylase Activity: a Study of the Structure-Activity RelationshipMolecular Pharmacology, 1977
- Separation of pure polychlorinated biphenyl isomers into two types of inducers on the basis of induction of cytochrome P-450 or P-448Chemico-Biological Interactions, 1977
- RAPID EMERGENCE OF CARCINOGEN-INDUCED HYPERPLASTIC LESIONS IN A NEW MODEL FOR SEQUENTIAL-ANALYSIS OF LIVER CARCINOGENESIS1977
- Polychlorinated biphenyl(s) as a promotor in experimental hepatocarcinogenesis in ratsJournal of Cancer Research and Clinical Oncology, 1976
- CELLULAR ANALYSIS OF LIVER CARCINOGENESIS - INDUCTION OF LARGE HYPERPLASTIC NODULES IN LIVER WITH 2-FLUORENYLACETAMIDE OR ETHIONINE AND SOME ASPECTS OF THEIR MORPHOLOGY AND GLYCOGEN METABOLISM1967
- EFFECTS OF AFLATOXIN B1 AND DIMETHYLSULFOXIDE ON THYMIDINE-3H UPTAKE AND MITOSIS IN RAT LIVER1967
- Development of Preneoplastic and Neoplastic Lesions of the Liver in Male Rats Given 0.025 Percent N-2-Fluorenyldiacetamide2JNCI: Journal of the National Cancer Institute, 1965